Clinical Trial Update: Non Neutralizing Antibodies: Prevalence and Characterization

View source ↗

Summary

This clinical trial update reports the withdrawal of a study evaluating non-neutralizing antibodies in Hemophilia A.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemophilia

Snippet

Sponsor: University Hospital, Montpellier | Conditions: Hemophilia A | Status: WITHDRAWN